3-iodobenzylguanidine has been researched along with Nausea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleeker, G; Caron, HN; de Kraker, J; Hoefnagel, CA; Schoot, RA; Tytgat, GA; van Eck, BL | 1 |
| Lin, WY; Shen, YY; Wang, SJ | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Nausea
| Article | Year |
|---|---|
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis.
Topics: 3-Iodobenzylguanidine; Anemia; Child; Child, Preschool; Female; Humans; Infant; Male; Nausea; Neuroblastoma; Radiopharmaceuticals; Retrospective Studies; Thrombocytopenia; Vomiting | 2013 |
1 other study(ies) available for 3-iodobenzylguanidine and Nausea
| Article | Year |
|---|---|
Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Nausea; Pain; Prospective Studies; Radionuclide Imaging; Radiotherapy, Adjuvant; Thyroid Neoplasms; Xerostomia | 1996 |